<?xml version='1.0' encoding='utf-8'?>
<document id="29186530"><sentence text="Stability of Synthetic Piperazines in Human Whole Blood."><entity charOffset="23-34" id="DDI-PubMed.29186530.s1.e0" text="Piperazines" /></sentence><sentence text="While circumventing legislative controls, synthetic piperazines are encountered as &quot;legal&quot; alternatives to ecstasy"><entity charOffset="52-63" id="DDI-PubMed.29186530.s2.e0" text="piperazines" /></sentence><sentence text=" Unforeseeable challenges may delay quantitative analysis of these compounds in biological fluids" /><sentence text=" Enzymatic reactions, matrix interferences and limited knowledge of analyte stability further complicate interpretation of calculated concentrations" /><sentence text=" The objective of this study was to investigate the stability of synthetic piperazines in human blood under various storage conditions over time"><entity charOffset="75-86" id="DDI-PubMed.29186530.s5.e0" text="piperazines" /></sentence><sentence text=" All samples were prepared by spiking certified reference standards (Cayman Chemical, MI, U" /><sentence text="S" /><sentence text="A" /><sentence text=") of eight synthetic piperazine into certified drug-free human whole blood (UTAK Laboratories, Inc"><entity charOffset="21-31" id="DDI-PubMed.29186530.s9.e0" text="piperazine" /></sentence><sentence text=", CA, U" /><sentence text="S" /><sentence text="A" /><sentence text=") independently at 1000 ng/mL as well as mixtures containing all tested piperazines in this study"><entity charOffset="72-83" id="DDI-PubMed.29186530.s13.e0" text="piperazines" /></sentence><sentence text=" Samples were stored at room temperature (~20°C), 4°C and -20°C for 1, 3, 6, 9 and 12 months in dark sealed containers" /><sentence text=" Solid phase extraction (SPE) was performed using mixed-mode copolymeric cartridges (Clean Screen®, UCT Inc" /><sentence text=", PA, U" /><sentence text="S" /><sentence text="A" /><sentence text=")" /><sentence text=" Analytes were assessed on their degrees of degradation using a Shimadzu Ultra-Fast Liquid Chromatograph with SCIEX 4000 Q-Trap Electrospray Ionization Tandem Mass Spectrometer (UFLC-ESI-MS/MS) in positive ionization mode" /><sentence text=" Of the two categories, benzyl piperazines were more stable than phenyl piperazines under all storage conditions, in which 1-(4-methylbenzyl)-piperazine (MBZP) had more than 70% (769-1,047 ng/mL) remaining after 12 months"><entity charOffset="24-42" id="DDI-PubMed.29186530.s21.e0" text="benzyl piperazines" /><entity charOffset="65-83" id="DDI-PubMed.29186530.s21.e1" text="phenyl piperazines" /><entity charOffset="123-152" id="DDI-PubMed.29186530.s21.e2" text="1-(4-methylbenzyl)-piperazine" /><entity charOffset="154-158" id="DDI-PubMed.29186530.s21.e3" text="MBZP" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e0" e2="DDI-PubMed.29186530.s21.e0" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e0" e2="DDI-PubMed.29186530.s21.e1" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e0" e2="DDI-PubMed.29186530.s21.e2" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e0" e2="DDI-PubMed.29186530.s21.e3" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e1" e2="DDI-PubMed.29186530.s21.e1" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e1" e2="DDI-PubMed.29186530.s21.e2" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e1" e2="DDI-PubMed.29186530.s21.e3" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e2" e2="DDI-PubMed.29186530.s21.e2" /><pair ddi="false" e1="DDI-PubMed.29186530.s21.e2" e2="DDI-PubMed.29186530.s21.e3" /></sentence><sentence text=" 1-(4-methoxyphenyl)-piperazine (MeOPP) was not detected under room and refrigerated temperatures after 6 months and was the least stable"><entity charOffset="1-31" id="DDI-PubMed.29186530.s22.e0" text="1-(4-methoxyphenyl)-piperazine" /><entity charOffset="33-38" id="DDI-PubMed.29186530.s22.e1" text="MeOPP" /><pair ddi="false" e1="DDI-PubMed.29186530.s22.e0" e2="DDI-PubMed.29186530.s22.e0" /><pair ddi="false" e1="DDI-PubMed.29186530.s22.e0" e2="DDI-PubMed.29186530.s22.e1" /></sentence><sentence text=" Matrix interferences and drug-drug interaction were observed" /><sentence text=" Storing samples at room temperature should be avoided due to detrimental impacts on stability of piperazine compounds"><entity charOffset="98-108" id="DDI-PubMed.29186530.s24.e0" text="piperazine" /></sentence><sentence text=" For backlog situations, case samples suspected to contain synthetic piperazines should be kept frozen or refrigerated even for time periods as short as 30 days for optimal result"><entity charOffset="69-80" id="DDI-PubMed.29186530.s25.e0" text="piperazines" /></sentence><sentence text=" Phenyl piperazines stored for more than 6 months showed analyte degradation and loss of parent compounds after extended storage regardless of storage conditions"><entity charOffset="1-19" id="DDI-PubMed.29186530.s26.e0" text="Phenyl piperazines" /></sentence><sentence text="" /></document>